JPWO2024181437A5 - - Google Patents
Info
- Publication number
- JPWO2024181437A5 JPWO2024181437A5 JP2025503931A JP2025503931A JPWO2024181437A5 JP WO2024181437 A5 JPWO2024181437 A5 JP WO2024181437A5 JP 2025503931 A JP2025503931 A JP 2025503931A JP 2025503931 A JP2025503931 A JP 2025503931A JP WO2024181437 A5 JPWO2024181437 A5 JP WO2024181437A5
- Authority
- JP
- Japan
- Prior art keywords
- phenanthrolin
- indazol
- amino
- solvate
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025148435A JP2026000973A (ja) | 2023-02-28 | 2025-09-08 | Ｍｙｔ１阻害活性を有する含窒素複素環化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023029673 | 2023-02-28 | ||
| JP2023029673 | 2023-02-28 | ||
| PCT/JP2024/007072 WO2024181437A1 (ja) | 2023-02-28 | 2024-02-27 | Ｍｙｔ１阻害活性を有する含窒素複素環化合物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025148435A Division JP2026000973A (ja) | 2023-02-28 | 2025-09-08 | Ｍｙｔ１阻害活性を有する含窒素複素環化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2024181437A1 JPWO2024181437A1 (https=) | 2024-09-06 |
| JP7742517B2 JP7742517B2 (ja) | 2025-09-19 |
| JPWO2024181437A5 true JPWO2024181437A5 (https=) | 2025-10-02 |
Family
ID=92589871
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025503931A Active JP7742517B2 (ja) | 2023-02-28 | 2024-02-27 | Ｍｙｔ１阻害活性を有する含窒素複素環化合物 |
| JP2025148435A Pending JP2026000973A (ja) | 2023-02-28 | 2025-09-08 | Ｍｙｔ１阻害活性を有する含窒素複素環化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025148435A Pending JP2026000973A (ja) | 2023-02-28 | 2025-09-08 | Ｍｙｔ１阻害活性を有する含窒素複素環化合物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20260062412A1 (https=) |
| EP (1) | EP4647424A1 (https=) |
| JP (2) | JP7742517B2 (https=) |
| KR (1) | KR20250153810A (https=) |
| CN (1) | CN120677145A (https=) |
| AR (1) | AR131956A1 (https=) |
| AU (1) | AU2024229746A1 (https=) |
| CL (1) | CL2025002607A1 (https=) |
| CO (1) | CO2025011476A2 (https=) |
| CR (1) | CR20250376A (https=) |
| IL (1) | IL322675A (https=) |
| MX (1) | MX2025010048A (https=) |
| PE (1) | PE20252436A1 (https=) |
| TW (1) | TW202446768A (https=) |
| WO (1) | WO2024181437A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025182927A1 (ja) * | 2024-02-27 | 2025-09-04 | 中外製薬株式会社 | Ｍｙｔ１阻害剤の用途 |
| WO2026054022A1 (ja) * | 2024-09-05 | 2026-03-12 | 中外製薬株式会社 | Ｍｙｔ１阻害活性を有する含窒素複素環化合物の製剤 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3202661A (en) * | 1962-11-27 | 1965-08-24 | Hoffmann La Roche | Substituted 3-amino 4-phenyl quinolones |
| US4014883A (en) * | 1973-09-10 | 1977-03-29 | Hoffmann-La Roche Inc. | Indoloquinolines, intermediates and processes |
| AU742452B2 (en) * | 1997-08-28 | 2002-01-03 | Bristol-Myers Squibb Company | 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators |
| WO2002076396A2 (en) * | 2001-03-23 | 2002-10-03 | Smithkline Beecham Corporation | Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases |
| CA2539760C (en) * | 2003-09-23 | 2011-01-25 | Merck & Co., Inc. | Quinoline potassium channel inhibitors |
| GB0420970D0 (en) * | 2004-09-21 | 2004-10-20 | Smithkline Beecham Corp | Novel triazoloquinoline compounds |
| WO2015088564A1 (en) * | 2013-12-13 | 2015-06-18 | Sunovion Pharmaceuticals Inc. | P2x4 receptor modulating compounds |
| US11026937B2 (en) * | 2016-09-12 | 2021-06-08 | Padlock Therapeutics, Inc. | Heteroaryl inhibitors of PAD4 |
| CN109111426B (zh) * | 2017-06-23 | 2021-12-14 | 中国科学院上海药物研究所 | 一类稠合双环杂芳基或芳基化合物，及其用途 |
| US20240398799A1 (en) * | 2021-08-19 | 2024-12-05 | Engine Biosciences Pte. Ltd. | Compositions and methods for generating synthetic lethality in tumors |
| CN114369061B (zh) * | 2022-01-28 | 2024-05-03 | 济南同路医药科技发展有限公司 | 一种氯硝西泮有关物质b的制备方法 |
| WO2024048687A1 (ja) * | 2022-08-31 | 2024-03-07 | 中外製薬株式会社 | Ｍｙｔ１阻害剤と化学療法剤を併用する、ｒｂ１の機能低下が生じている患者のがんの治療剤及び治療方法 |
-
2024
- 2024-02-27 KR KR1020257031004A patent/KR20250153810A/ko active Pending
- 2024-02-27 PE PE2025001752A patent/PE20252436A1/es unknown
- 2024-02-27 EP EP24763916.4A patent/EP4647424A1/en active Pending
- 2024-02-27 TW TW113107016A patent/TW202446768A/zh unknown
- 2024-02-27 IL IL322675A patent/IL322675A/en unknown
- 2024-02-27 AR ARP240100443A patent/AR131956A1/es unknown
- 2024-02-27 JP JP2025503931A patent/JP7742517B2/ja active Active
- 2024-02-27 CR CR20250376A patent/CR20250376A/es unknown
- 2024-02-27 WO PCT/JP2024/007072 patent/WO2024181437A1/ja not_active Ceased
- 2024-02-27 AU AU2024229746A patent/AU2024229746A1/en active Pending
- 2024-02-27 CN CN202480012274.4A patent/CN120677145A/zh active Pending
-
2025
- 2025-08-25 US US19/308,769 patent/US20260062412A1/en active Pending
- 2025-08-26 CO CONC2025/0011476A patent/CO2025011476A2/es unknown
- 2025-08-26 MX MX2025010048A patent/MX2025010048A/es unknown
- 2025-08-27 CL CL2025002607A patent/CL2025002607A1/es unknown
- 2025-09-08 JP JP2025148435A patent/JP2026000973A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2024181437A5 (https=) | ||
| ZA202209563B (en) | Biaryl derivatives as yap/taz-tead protein-protein interaction inhibitors | |
| CN1878757A (zh) | 吡啶酮衍生物及其应用 | |
| JOP20220155A1 (ar) | مشتقات البيرازول مفيدة كعوامل مضادة للسرطان | |
| AR050838A1 (es) | Formulacion farmaceutica. para el tratamiento de una infeccion optica | |
| IL311376B2 (en) | Azetidine and pyrrolidine parp1 inhibitors and uses thereof | |
| IL314009B1 (en) | Parp1 inhibitors and uses thereof | |
| CA2430065A1 (en) | Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents | |
| JP2004506009A5 (https=) | ||
| JP2000159790A5 (https=) | ||
| IL294247B2 (en) | (2r,4r)-1-(3-chloro-2-fluorobenzyl)-4-((5-fluoro-4-methyl-6-((5-methyl-1h-pyrazol-3-yl)amino)pyridin-2-yl)methyl)-2-methylpiperidine-4-carboxylic acid and a pharmaceutical composition comprising the compound or pharmaceutically acceptable salt thereof | |
| JP2010511631A5 (https=) | ||
| WO2007002313A3 (en) | Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants | |
| JP2019151627A5 (https=) | ||
| SA523442503B1 (ar) | مشتقات سبيروبيبريدينيل مستبدل بأريل غير متجانس واستخدامات صيدلانية لها | |
| WO2024100452A3 (en) | Heterocyclic compounds as sting agonists | |
| CO2022008616A2 (es) | Composición farmacéutica oral que comprende compuesto de carbamato y método de preparación para la misma | |
| CA2489140A1 (en) | Dosage form containing pantoprazole as active ingredient | |
| WO2023217201A3 (zh) | 作为Wee1抑制剂的新型嘧啶并杂环类新化合物及其应用 | |
| JP2025507472A5 (https=) | ||
| JP2021505578A5 (https=) | ||
| JPWO2024111636A5 (https=) | ||
| IL315035A (en) | Process for preparing {6-[(diethylamino)methyl]naphthalen-2-yl}methyl [4-(hydroxycarbamoyl)phenyl]carbamate having high purity | |
| NO20070421L (no) | Radiosensitiviserende middel | |
| WO2023141522A3 (en) | Multicyclic compounds |